Clinical Software in Vermont

Data Innovations LLC is a software solutions provider specializing in laboratory enterprise management and middleware platforms. The company develops vendor-neutral connectivity and workflow optimization software for clinical laboratories, serving 6,000+ hospitals and labs across 80+ countries. Their primary product line includes Instrument Manager (middleware platform for lab instrument connectivity and autoverification workflows), EP Evaluator (instrument performance validation and regulatory compliance reporting), and Lab GPS (real-time connectivity monitoring and downtime troubleshooting). Data Innovations enables labs to streamline operations, improve productivity, reduce manual tasks, accelerate test turnaround times, and ensure compliance through customizable automation and centralized workflow management. The company positions itself as supporting all laboratory disciplines with unlimited scalability and flexible, vendor-agnostic architecture. Their client base includes major health systems (Sanford, UNC Rex, Valley Children's Hospital, University of Iowa, VA Medical Centers) and laboratory networks. Data Innovations operates globally with headquarters in Colchester, Vermont and regional offices in São Paulo, Hong Kong, and Brussels, employing 1,200+ drivers/support staff worldwide.

Head Diagnostics Ltd is an Irish medtech company specializing in clinically validated AI-driven digital solutions for neurological assessment and brain health management. The company develops cloud-based software platforms and handheld medical devices focused on cognitive assessment, neuropsychological testing, and brainstem function evaluation. Primary product: HDx Cognition (formerly IntelliSpace Cognition, originally developed by Philips) is a cloud-based Software-as-a-Service platform for comprehensive, digitized neuropsychological assessment across six cognitive domains. The platform comprises a patient tablet interface and clinician PC/tablet interface, delivering immediate scoring, normative comparisons, and automated reporting. Assessments align with established neuropsychological measures and have been clinically validated through multiple U.S. clinical trials on demographically representative populations. Secondary product: iTremor is a handheld, non-invasive device using laser speckle metrology to measure Ocular Microtremor (OMT) as an indicator of brainstem function. It delivers objective neurological insights in three seconds; currently restricted to research use (not FDA cleared). The company targets clinical workflows in neurology, geriatrics, and memory clinics, supporting assessment and monitoring of mild cognitive impairment, dementia, Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, and traumatic brain injury. HDx Cognition is normed on large U.S. populations and demonstrates reliability and equivalence to traditional paper-based testing. The platform integrates with electronic health records and enables longitudinal patient monitoring and remote assessment with clinician oversight. Certifications and recognition: Red Dot Award (2020), iF Design Award (2020), UX Design Award (2020), 2023 AI in Healthcare Award, 2024 Irish Medtech Awards finalist, and George Sigerson Award (2024). Technology is grounded in decades of cognitive science research and developed in collaboration with leading clinicians, hospitals, universities, and research centers.